专利信息

查询条件展开筛选条件

[药品] 包含 'Abiraterone'

首页 1 2 3 4 5 6 下页尾页共 81 条记录, 当前第1/9页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 6 下页尾页共 81 条记录, 当前第1/9页。

当前查询条件: [药品] 包含 'Abiraterone'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP2694072A1	2014/2/12	EP20120764765	2012/3/30
专利标题：COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND METHODS OF USE 专利权人：GENENTECH INC [US];NANNINI MICHELLE [US];SAMPATH DEEPAK [US];

2. CN103570791A	2014/2/12	CN20121264405	2012/7/30
专利标题：The novel method of a kind of synthesis of acetic acid abiraterone ester (abiraterone acetate) 专利权人：

3. WO2014016830A1	2014/1/30	WO2013IL50621	2013/7/22
专利标题：PROCESS AND INTERMEDIATES FOR THE PREPARATION OF ABIRATERONE ACETATE 专利权人：MAPI PHARMA LTD [IL]; The present invention relates to a process for the synthesis of (3beta)17-(3- pyridinyl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) represented by the structure of formula (1), and salts thereof, especially salts with pharmaceutically acceptable acids. The present invention further relates to certain intermediates in such processes.

4. WO2014009437A1	2014/1/16	WO2013EP64622	2013/7/10
专利标题：OXIDATION STABILITY OF ABIRATERONE ACETATE 专利权人：SANDOZ AG [CH];GRAHEK ROK [SI];HOMAR MIHA [SI];ROZMAN PETERKA TANJA [SI];INJAC RADE [SI]; The present invention relates to a pharmaceutical composition comprising abiraterone acetate or a pharmaceutically acceptable salt, hydrate or solvate thereof, characterized in that the abiraterone acetate or a pharmaceutically acceptable salt, hydrate or solvate thereof is stabilized against oxidative degradation.

5. WO2014009436A1	2014/1/16	WO2013EP64620	2013/7/10
专利标题：NANOSUSPENSION OF ABIRATERONE ACETATE 专利权人：SANDOZ AG [CH];GRAHEK ROK [SI];KOCEVAR KLEMEN [SI];NOVAK STAGOJ MATEJA [SI];HOMAR MIHA [SI];ROZMAN PETERKA TANJA [SI];KLANCAR UROS [SI]; The present invention relates to a nanosuspension of abiraterone acetate or a pharmaceutically acceptable salt, hydrate or solvate thereof and a method of preparing the same. It further relates to a pharmaceutical composition comprising a nanosuspension of abiraterone acetate or a pharmaceutically active salt, hydrate or solvate thereof, and a method of preparing the same.

6. WO2014009434A1	2014/1/16	WO2013EP64618	2013/7/10
专利标题：SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM OF ABIRATERONE OR ABIRATERONE ACETATE 专利权人：SANDOZ AG [CH];LEGEN IGOR [SI];PETERNEL LUKA [SI];NOVAK STAGOJ MATEJA [SI];HOMAR MIHA [SI];ROZMAN PETERKA TANJA [SI];KLANCAR UROS [SI]; The present invention relates to a self-microemulsifying drug delivery system comprising a compound of formula (I), preferably abiraterone or abiraterone acetate or a pharmaceutically acceptable salt, hydrate or solvate thereof, at least one fatty acid ester and at least one surfactant. The invention further relates to a method of preparing the same and to a pharmaceutical composition comprising the self- microemulsifying drug delivery system.

7. US2014011992A1	2014/1/9	US201213721204	2012/12/20
专利标题：SYNTHESIS OF ABIRATERONE AND RELATED COMPOUNDS 专利权人：CRYSTAL PHARMA S A U [ES]; The present invention relates to processes for obtaining abiraterone and derivatives thereof, such as abiraterone acetate, by means of a Suzuki coupling through a steroid borate of general formula (IV) or a C-C coupling through a steroid hydrazone of general formula (II), as well as to intermediates useful in said processes.

8. US20140011992A1	2014/1/9	US13/721204	2012/12/20
专利标题：Synthesis of abiraterone and related compounds 专利权人：Crystal Pharma, S.a.u.; The present invention relates to processes for obtaining abiraterone and derivatives thereof such as abiraterone acetate by means of a Suzuki coupling through a steroid borate of general formula (IV) or a C-C coupling through a steroid hydrazone of general formula (II) as well as to intermediates useful in said processes.

9. CN103450313A	2013/12/18	CN20131364842	2013/8/21
专利标题：Preparation method of abiraterone acetate 专利权人：SUZHOU MINGYUE MEDICAL TECHNOLOGY CO LTD;XU XUENONG;

10. CN103446069A	2013/12/18	CN20121169791	2012/5/29
专利标题：Oral solid composition of abiraterone and preparation method thereof 专利权人：CHONGQING PHARM RES INST CO;

下载范围

下载内容